#pluripotent stem cells

[mindblowingscience]

Scientists already have their ways of coaxing human cells into new forms, using a special concoction of chemicals to nudge humble skin cells into malleable tissues known as induced pluripotent stem cells. In spite of this new lease on life, these particular cells still retain a few genetic reminders of their time as a fully developed tissue, affecting their use as a blank slate. Now an international team of researchers has gone one better: finding a new way of wiping a cell's memory clean so it can be better reprogrammed as a stem cell.

Continue Reading.

[humancelltournament]

Human Cell Tournament Round 1

Propaganda!

Mucosal-associated invariant T cells (MAIT cells) make up a subset of T cells in the immune system that display innate, effector-like qualities. In humans, MAIT cells are found in the blood, liver, lungs, and mucosa, defending against microbial activity and infection. After the presentation of foreign antigen by MR1, MAIT cells secrete pro-inflammatory cytokines and are capable of lysing bacterially-infected cells. MAIT cells are thought to play a role in autoimmune diseases, such as multiple sclerosis, arthritis and inflammatory bowel disease, although definitive evidence is yet to be published. Like all T cell subsets, MAIT cells develop in the thymus. [image credit]

In cell biology, pluripotency refers to a stem cell that has the potential to differentiate into any of the three germ layers: endoderm (gut, lungs and liver), mesoderm (muscle, skeleton, blood vascular, urogenital, dermis), or ectoderm (nervous, sensory, epidermis), but not into extra-embryonic tissues like the placenta or yolk sac.

[panthera-tigris-venenata]

I just saw a biolgy word I learned for a test in a ya dystology and it makes me so angry-

[smokszyvverstar]

Told my professor that i read a bunch of papers and didnt understand anything and he said that it'll probably be at about 10 to 20 papers that things will finally start falling into place. Because im new to that area

And i needed to hear that

I felt stupid because i wasnt understanding high level professional scientific papers in a field that the only thing i knew about it before is "oh yea, it exists"

And maybe you need to hear it too. And maybe Im posting this just so i can finally internalise it.

You wont understand everything the first time you study it. It will take weeks, months, years. And thats ok. Thats normal.

So sit down and allow yourself to reread the same paragraph five times because you dont understand. Thats how learning starts.

And the best thing is, that even after decades, you wont know everything. So its ok to not know everything

[the-trans-dragon]

https://www.tumblr.com/mousegirlheart/712995877228298240/mouse-yaoi-real

Idk it seems ciscentered, trans excluding to treat “male mice” like a coherent thing — rather than some construct we assign to them like how we assign it with amab people — and then further to conflate 2 male mice together as being yaoi and gay… it reinforces being “male” (amab) as a biological thing not something to do with gender and identity.

Hmmm... I can't seem to see things from your perspective. Is the only issue that it says "mouse yaoi real"?

I reblogged because it's incredibly cool that it happened! It helps dissolve our rigid ideas of sex, in my opinion. One of the biggest trans-exclusionary arguments in my current culture is "women are women because they can bear children," which ties into the ever-present homophobic argument of "homosexuality is wrong because it cannot produce offspring."

The ramifications for this sort of thing are still "up in the air," so to speak, since experiments with mice cannot always be replicated in humans. But the ability to create a viable offspring from a same-sex pair of mammalian model organisms is still a big break-through, especially because of the implications of creating an egg with two X chromosomes from a male skin cell with only one X chromosome! As the CNN article itself explains,

"The proof-of-concept research, the culmination of years of pain-staking lab work, could expand the possibilities for future fertility treatments, including for same-sex couples, and perhaps help prevent the extinction of endangered animals. "

The ability to create viable offspring from "male" cells is a direct wound to the idea that "male" is a rigid characteristic. If I allow myself to daydream, I can ponder other possibilities: could you turn "male" skin cells into other cells? Could a trans woman one day have her own cells used to grow a uterus? Growing entire organs is a wholly different feat, compared to creating a single gamete, with difficulties such as incorporating it into a pre-existing organism (eg, even if you could grow a uterus, could you get it connected to the circulatory system?). It's a far-off daydream, thanks to the current culture's fear of research that questions it's rigid ideas of sex and gender. But it's a daydream that comes closer to being reality when science achieves breakthroughs like this!

I am being overly hopeful. Science is very slow to make progress in regards to sex. Progress is discouraged and poorly funded, and can even be destroyed, such as with the Hirshfield Institution. But seeing science make progress like this, despite the hostile culture, gives me hope in itself.

It's unfortunate that our current vocabulary is inadequate and rife with bias that assumes everything is cisgender, heterosexual, and perisex. In our efforts to understand the unbiased nature of sex, it's important to examine our views for these issues. Does "mouse yaoi real" contribute to cis-centric, trans-exclusionary biases? I dunno. No. Yeah. Sure. It doesn't matter. Or maybe it does.

Anyways, the science is really really really really cool. I have other thoughts on the matter, but my vocabulary feels inadequate to verbalize them, and instead I am just taking a moment here to talk about the science a little, explain how it can be utilized as a step towards trans healthcare, and emphasize the importance of celebrating these things.

[industryforecastnews]

Induced Pluripotent Stem Cells Production Market To Reach USD 2.76 Billion By 2030

Induced Pluripotent Stem Cells Production Market Growth & Trends

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

Induced Pluripotent Stem Cells Production Market Report Highlights

By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.

By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.

By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.

By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.

By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.

North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace. 

Induced Pluripotent Stem Cells Production Market Segmentation

Grand View Research has segmented the global induced pluripotent stem cells production market based on process, workflow, product, application, end-use, and region:

Induced Pluripotent Stem Cells Production Process Outlook (Revenue, USD Million, 2018 - 2030)

Manual iPSC Production Process

Automated iPSC Production Process

Induced Pluripotent Stem Cells Production Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Reprogramming

Cell Culture

Cell Characterization/Analysis

Engineering

Others

Induced Pluripotent Stem Cells Production Product Outlook (Revenue, USD Million, 2018 - 2030)

Instruments/ Devices

Automated Platforms

Consumables & Kits

Media

Kits

Others

Services

Induced Pluripotent Stem Cells Production Application Outlook (Revenue, USD Million, 2018 - 2030)

Drug Development & Discovery

Regenerative Medicine

Toxicology Studies

Others

Induced Pluripotent Stem Cells Production End-use Outlook (Revenue, USD Million, 2018 - 2030)

Research & Academic Institutes

Biotechnology & Pharmaceutical Companies

Hospitals & Clinics

Induced Pluripotent Stem Cells Production Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Induced Pluripotent Stem Cells Production Market

Lonza

Axol Bioscience Ltd.

Evotec

Hitachi, Ltd.

REPROCELL Inc.

Merck KGaA

REPROCELLS, Inc.

Fate Therapeutics

Thermo Fisher Scientific, Inc.

StemCellsFactory III

Applied StemCells, Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

[creativeera]

The Global Induced Pluripotent Stem Cells Market is Trending Towards Personalized Medicine

The global induced pluripotent stem cells market is witnessing trends towards personalized medicine as induced pluripotent stem cells provide a patient-specific approach to develop cell therapies. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state through the forced expression of transcription factors. These cells can be generated directly from adult tissues such as skin or blood and can proliferate indefinitely. Once reprogrammed, iPSCs can be differentiated into many other cell types such as nerve cells, heart cells, pancreatic cells and others. This unique capability offers enormous promise for regenerative medicine and disease modelling. The global induced pluripotent stem cells market was valued at US$ 1,595.4 Mn in 2023 and is expected to reach US$ 3,707 Mn by 2031, growing at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.  

iPSCs provide a potential alternative to human embryonic stem cells for disease modeling, drug discovery, and cell-based regenerative therapies. These cells circumvent controversies of using embryonic stem cells and the need for harvesting tissue-specific stem cells from adult tissues. This has led to an increase in research activities using iPSCs to model neurodegenerative diseases, cardiovascular diseases, and explore opportunities for cellular therapies. Key Takeaways Key players operating in the global induced pluripotent stem cells market are Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines and Other Prominent Players. These players are investing in developing new cell reprogramming and differentiation techniques which will enable mass production of iPSCs. The Global Induced Pluripotent Stem Cells Market Demand for induced pluripotent stem cells is growing due to increased investments in stem cell research and regenerative medicine. Many pharmaceutical companies are investing in developing personalized stem cell-based therapies and iPSC-derived disease models for drug discovery. Furthermore, increased awareness about potential applications of stem cell therapies is also boosting the demand. Key players are expanding globally to cater to the growing needs of research organizations and pharmaceutical companies. Companies are focusing on establishing facilities in Asia Pacific and Europe through partnerships and acquisitions. This is attributed to presence of considerable stem cell research bases and favorable regulations supporting research in these regions. Market Key Trends The Global Induced Pluripotent Stem Cells Market Size and Trends is witnessing trends towards three-dimensional (3D) culture techniques. 3D culture enables iPSC expansion as well as differentiation into various cell types in an environment that closely mimics in vivo conditions. Several companies are developing 3D bioprocessing platforms using hydrogels and biomaterials to facilitate mass production of iPSCs in a clinically relevant manner. This 3D culture technique is gaining popularity as it enhances stem cell growth, viability and differentiation potential. Porter's Analysis Threat of new entrants: New entrants face high initial costs of setting up research and production facilities for iPSCs. Bargaining power of buyers: Buyers have low bargaining power due to limited availability of substitutes and differentiated products offered by existing players. Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative raw material sources and suppliers. Threat of new substitutes: Threat of substitutes is low as iPSCs offer significant advantages over other alternatives. Competitive rivalry: Market is consolidated with presence of few players conducting research on regenerative medicines using iPSCs. Geographical Regions North America accounts for the largest share of the global iPSCs market, primarily due to presence of major players and availability of research funding. Presence of advanced healthcare infrastructure and rising stem cell therapy adoption in the U.S. and Canada drives the regional market. Asia Pacific is poised to witness the fastest growth over the forecast period. Increasing initiative by governments in countries such as China, Japan, and India to develop domestic regenerative medicine industry presents lucrative growth opportunities. Additionally, lower labor and manufacturing costs attract companies to establish manufacturing facilities in Asia Pacific.

Get more insights on Global Induced Pluripotent Stem Cells Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[airises]

What are induced pluripotent stem cells, and how are they different from embryonic stem cells?

What are induced pluripotent stem cells (iPSCs)? Reprogrammed adult cells: iPSCs are created in the lab by taking adult cells (often skin or blood cells) and genetically reprogramming them back to an immature, embryo-like state. Pluripotency: Like embryonic stem cells, iPSCs are pluripotent. This means they have the exceptional potential to develop into almost any type of cell in the body. Key…

[digimarketresearch]

Induced Pluripotent Stem Cells Market Size, Share, Trends, Global Demand, Growth and Opportunity Analysis

"Induced Pluripotent Stem Cells (iPSCs) Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The large scale Induced Pluripotent Stem Cells (iPSCs) Market report is prepared by taking into account the market type, organization volume, accessibility on-premises, end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. Extremely talented pool has invested a lot of time for doing market research analysis and to generate this market report. Induced Pluripotent Stem Cells (iPSCs) Market report is sure to help businesses for the long lasting accomplishments in terms of better decision making, revenue generation, prioritizing market goals and profitable business.

Access Full 350 Pages PDF Report @

The global induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,081.08 million by 2029. Increasing research activities over stem cell therapies act as driver for the induced pluripotent stem cells (iPSCs) market growth.

Key Coverage in the Induced Pluripotent Stem Cells (iPSCs) Market Report:

Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the Induced Pluripotent Stem Cells (iPSCs) industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Induced Pluripotent Stem Cells (iPSCs) Market Landscape

Part 04: Global Induced Pluripotent Stem Cells (iPSCs) Market Sizing

Part 05: Global Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The major companies which are dealing in the induced pluripotent stem cells (iPSCs) are Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte,  Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia, Inc. and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Dupuytrens Disease Market

Mitogen Activated Protein Kinase Mapk Inhibitors Therapeutics Market

Neonatal Seizures Drugs Market

Chikungunya Treatment Market

Sickle Cell Disease Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com"

[aimarketresearch]

Induced Pluripotent Stem Cells Market Size, Share, Trends, Demand, Future Growth, Challenges and Competitive Analysis

Induced Pluripotent Stem Cells (iPSCs) Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The large scale Induced Pluripotent Stem Cells (iPSCs) Market report is prepared by taking into account the market type, organization volume, accessibility on-premises, end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. Extremely talented pool has invested a lot of time for doing market research analysis and to generate this market report. Induced Pluripotent Stem Cells (iPSCs) Market report is sure to help businesses for the long lasting accomplishments in terms of better decision making, revenue generation, prioritizing market goals and profitable business.

Access Full 350 Pages PDF Report @

The global induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,081.08 million by 2029. Increasing research activities over stem cell therapies act as driver for the induced pluripotent stem cells (iPSCs) market growth.

Key Coverage in the Induced Pluripotent Stem Cells (iPSCs) Market Report:

Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the Induced Pluripotent Stem Cells (iPSCs) industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Induced Pluripotent Stem Cells (iPSCs) Market Landscape

Part 04: Global Induced Pluripotent Stem Cells (iPSCs) Market Sizing

Part 05: Global Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The major companies which are dealing in the induced pluripotent stem cells (iPSCs) are Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte,  Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia, Inc. and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Digital Mobile X Ray Devices Market

Point Of Care Poc Urinalysis Market

Viral Clearance Services Market

Preparative And Process Chromatography Market

Next Generation Dna Sequencing Ngs Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[charliefooks]

Getting my head around stem cells totipotent, pluripotent, multipotent

[k-star-holic]

Induced Pluripotent Stem Cell Broadcaster Ahn Hye-kyung from Weather Report Girl is a bride of September!

Source: k-star-holic.blogspot.com

[realanurag-blog]

स्टेम सेल:आधुनिक चिकित्सा का एक नया अविष्कार

स्टेम सेल (Stem Cell) एक ऐसा सेल होता है जो विभिन्न प्रकार के रक्त, हड्डियों, लीवर, ब्रेन और अन्य अंगों के उत्पादन में सहायता करता है। स्टेम सेल की विशेषता यह है कि यह अन्य सेलों की तरह नहीं होती है। यह अनेक प्रकार की सेलों में बदल सकती है और शरीर के अन्य अंगों की भी उत्पादन कर सकती है।

विज्ञान दुनिया में अब तक तीन प्रकार की स्टेम सेलों की पहचान की गई है

एमब्रायोनिक स्टेम सेल (Embryonic Stem Cell) - ये सेल गर्भावस्था के प्रारंभिक दिनों में उत्पन्न होती हैं। इन सेलों का उत्पादन बच्चे के गर्भ में होता है। इन सेलों का उत्पादन बच्चे के विकास के दौरान बंद हो जाता है। इन सेलों का उत्पादन करने के लिए गर्भवती महिलाओं से एक छोटा सा टिश्यू लिया जाता है जिससे ये सेल उत्पन्न होती हैं। एम्ब्रायोनिक स्टेम सेल विभिन्न तरह की सेलों में बदल सकती हैं।

एडल्ट स्टेम सेल (Adult Stem Cell) - ये सेल विभिन्न अंगों में मौजूद होती हैं। इन सेलों का उत्पादन शरीर के विकास के दौरान होता है। इन सेलों का उत्पादन करने के लिए शरीर से एक छोटा सा टिश्यू लिया जाता है जिससे ये सेल उत्पन्न होती हैं। एडल्ट स्टेम सेल उ��्हें सेलों में बदलने की क्षमता रखती हैं जिस अंग में वे मौजूद होती हैं।

इंडुस्ट्रियल स्टेम सेल (Induced Pluripotent Stem Cell) - ये सेल लैब में उत्पन्न की जाती हैं। इन सेलों का उत्पादन शरीर के विकास के दौरान नहीं होता है। इन सेलों का उत्पादन करने के लिए शरीर से छोटे से टिश्यू को लैब में लाया जाता है जिससे ये सेल उत्पन्न होती हैं। इंडुस्ट्रियल स्टेम सेल विभिन्न तरह की सेलों में बदल सकती हैं।

स्टेम सेल विज्ञान में एक बड़ी उम्मीद है। इन सेलों की मदद से विभिन्न रोगों का इलाज किया जा सकता है। इन सेलों की खोज ने न केवल वैज्ञानिकों को बल्कि बीमार लोगों को भी नई जिंदगी दी है। इसके अलावा इन सेलों को उपयोग कर मानव शरीर के विभिन्न अंगों को बदला जा सकता है।

इसलिए, स्टेम सेल विज्ञान एक बहुत ही रोचक विषय है। इन सेलों के बारे में अधिक जानकारी के लिए आप अपने निकटतम वैज्ञानिक से संपर्क कर सकते हैं।